Cargando…
p21‐activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1
Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant tumors of the digestive tract in humans. Several studies have indicated that PAK4 is associated with the risk of ESCC and may be a potential druggable kinase for ESCC treatment. However, the underlying mechanism remains la...
Autores principales: | Huang, Hui, Xue, Qianqian, Du, Xiaoge, Cui, Jie, Wang, Jing, Cheng, Dan, Li, Jiaqiong, Zheng, Yaqiu, Huang, Guojing, Zhang, Keke, Liu, Kangdong, Lu, Jing, Zhao, Jimin, Chen, Xinhuan, Dong, Ziming, Li, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756368/ https://www.ncbi.nlm.nih.gov/pubmed/33289209 http://dx.doi.org/10.1002/mc.23269 |
Ejemplares similares
-
TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2019) -
Correction to: TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2020) -
Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway
por: Yang, Yi, et al.
Publicado: (2017) -
Jie Du Tong Ye San Prevents N-Nitrosomethylbenzylamine-Induced Esophageal Carcinogenesis via Inhibition of Inflammation and Proliferation
por: Zhao, Simin, et al.
Publicado: (2019) -
Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K
por: Zhu, Lili, et al.
Publicado: (2020)